BCDDP: Breast cancer detection demonstration project follow-up study (1030) This study follows about 60,000 former participants in the Breast Cancer Demonstration Project (BCDDP). Current analyses include: 1) body mass index, hormone replacement therapy and breast cancer risk;2) risk factors for histologic types of breast cancer;3) risk factors according to breast cancer ER/PR status;4) hysterectomy status and all-cause and cause-specific mortality;5) alcohol consumption and breast cancer risk;5) dietary pooling project analyses involving cancers of the breast, colon, ovary, and kidney;and 6) DCEG pooling projects, including NSAIDS and bladder cancer risk. Gastric cancer: Randomized multi-intervention trial to inhibit precancerous gastric lesions in Linqu, Shandong Province (446) We gathered additional follow-up data for seven years following the end of an 8-year trial in rural China to determine whether any of three treatments would affect gastric cancer incidence or specific causes of mortality. The treatments were long-term vitamin (C, E, and selenium) supplementation and garlic supplementation, given from 1995 to 2003, and one time administration of amoxicillin/omeprazole given in 1995. Analyses of these data are underway. Inflammatory breast cancer (IBC) pilot study and case-control study (314) This case-control study will include approximately 400 IBC cases accrued over a two-year period at 4 centers in North Africa (1 center in Tunisia plus several private clinics, 2 in Egypt, and 2 in Morocco). Two control groups will be included: 1) 400 non-IBC breast cancer cases and;2) 400 visitor controls (excluding first-degree relatives) to randomly selected female inpatients (excluding those with breast, ovarian, endometrial, and nasopharyngeal cancer) in the study hospitals. The study will involve the administration of a questionnaire, anthropometric measurements, saliva collection, digital photographs of the breasts of IBC cases, and the collection of paraffin-embedded tumor tissue for IBC cases and non-IBC breast cancer controls at selected centers. The study will be conducted as a consortium with the University of Michigan, with forms development and translation coordinated at the National Cancer Institute-USA. The NCI-DCEG is responsible for developing study procedures at the study centers in Egypt, Tunisia, and Morocco. Data collection began in March 2009 in Egypt and August 2009 in Tunisia. IRB approval in Morocco is expected in

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIACP010182-08
Application #
8157934
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2010
Total Cost
$680,007
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
Zip Code
Gierach, Gretchen L; Pfeiffer, Ruth M; Patel, Deesha A et al. (2014) Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause 21:592-601
Schairer, Catherine; Li, Yan; Frawley, Peter et al. (2013) Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst 105:1373-84
Schairer, Catherine; Soliman, Amr S; Omar, Sherif et al. (2013) Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia. Cancer Med 2:178-84
Riedl, Regina; Engels, Eric A; Warren, Joan L et al. (2013) Blood transfusions and the subsequent risk of cancers in the United States elderly. Transfusion 53:2198-206
Ma, Jun-Ling; Zhang, Lian; Brown, Linda M et al. (2012) Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 104:488-92
Soliman, Amr S; Schairer, Catherine (2012) Considerations in setting up and conducting epidemiologic studies of cancer in middle- and low-income countries: the experience of a case-control study of inflammatory breast cancer in North Africa in the past 10 years. Cancer Med 1:338-49
Danforth, Kim N; Schairer, Catherine; Schatzkin, Arthur et al. (2009) Bone fractures and incident epithelial ovarian cancer in a prospective cohort study. J Womens Health (Larchmt) 18:1777-82
Pfeiffer, Ruth M; Mitani, Aya; Landgren, Ola et al. (2009) Timing of births and endometrial cancer risk in Swedish women. Cancer Causes Control 20:1441-9
Anderson, W F; Luo, S; Chatterjee, N et al. (2009) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 113:189-96
Johnson, Jill R; Lacey Jr, James V; Lazovich, Deann et al. (2009) Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 18:196-203

Showing the most recent 10 out of 11 publications